Improving Transparency and Accuracy in Medicare Part D Spending Act

Key: what the circles and colors mean

Each circle is a bill. The ring fills as it moves through Congress:

IntroducedPassed one chamberPassed both chambersBecame law (gold)Resolution agreed to (full, dark)Failed or vetoed (gray)

Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.

Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.

Never voted on. It didn't reach a floor vote before the 116th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.

D WelchSponsor

28 cosponsors · 8 D, 20 R

4 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.

Improving Transparency and Accuracy in Medicare Part D Spending Act

What it does: CRS summary · Introduced in House · Jan 25, 2019

Improving Transparency and Accuracy in Medicare Part D Spending Act

This bill prohibits Medicare prescription drug plan sponsors from retroactively reducing payment on clean claims submitted by pharmacies. (A "clean claim" is a Medicare claim that is free of defects such as incomplete documentation.)

Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov

About this bill and sources

Official title: Improving Transparency and Accuracy in Medicare Part D Spending Act

Latest action (Mar 1, 2019): Referred to the Subcommittee on Health.

Policy area: Health · Origin: House · Introduced: Jan 25, 2019

Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)

No recorded floor vote found.